2006 Fiscal Year Final Research Report Summary
Research for serum markers of radiosensitivity from cancer patients
| Project/Area Number |
17591269
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Kobe University |
|---|
Principal Investigator |
TANIGUCHI Takanori Kobe University, University Hospital, Lecturer, 医学部附属病院, 講師 (20346258)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SUGIMURA Kazuro Kobe University, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (00136384)
OKAMOTO Yoshiaki Kobe University Hospital, Lecturer, 医学部附属病院, 講師 (20362791)
SASAKI Ryohei Kobe University, Graduate School of Medicine, Associate Professor, 大学院・医学系研究科, 特命助教授 (30346267)
OTA Yosuke Kobe University Hospital, Resident, 医学部附属病院, 医員 (90397810)
|
|---|
| Project Period (FY) |
2005 – 2006
|
| Keywords | radiotherapy / radiosensitivity / marker / proteome |
|---|
| Research Abstract |
To search for novel serum markers of radiosensitivity for the cancer patients, we correlate the patient outcomes and the proteome phenotype from patients' serum.
Demizu et al. reported the Efficacy and feasibility of cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma in Japanese Journal Clinical Oncology.
Ejima et al. reported Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy in Radiotherapy and Oncology.
|
